IL6 and acute myeloid leukemia: To test whether IL-32θ expression suppresses proinflammatory cytokine production in AML, we first measured the production of TNF-α, IL-1β, and IL-6 in patients with AML compared the levels to that found in healthy individuals and patients with a severe inflammatory disease (Figure 2D).